The Frankel Innovation Initiative is a $20 million fund supporting the research and development of life-saving therapies at Michigan Medicine. Made possible by a generous donation from the Maxine and Stuart Frankel Foundation, the program is established to advance innovative research by U-M faculty, and their collaborators inside and outside U-M, that has the potential for rapid clinical application and groundbreaking impact. FFMI is administering the fund.
The $20 million gift will be used to fund four to seven projects annually, with each project receiving between $250,000 – $500,000. Collaborative projects that engage nationally renowned Co-PIs at other institutions are especially encouraged. Letters of Intent are due in May, and will be evaluated on the basis of eligibility and fund appropriateness. After Letters of Intent are reviewed by a triage committee, a select group of faculty will be invited to submit a full application for funding consideration.
The initiative is designed to build on best practices of the standout programs developed at U-M and other top institutions, and capitalizes on U-M’s extensive biomedical research enterprise as the top public university in research spending in the United States.